Industry Should ‘Lead From The Outside’ With US FDA Policy Staff Decimated, Woodcock Says

 
• By Derrick Gingery
  
External groups can lead on drug development policy, Janet Woodcock said. (Shutterstock)

More from Approval Standards

More from United States